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Transcript Specificity in Yeast Pre-mRNA
Splicing Revealed by Mutations
in Core Spliceosomal Components
Jeffrey A. Pleiss, Gregg B. Whitworth, Megan Bergkessel, Christine Guthrie
*
Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, United States of America
Appropriate expression of most eukaryotic genes requires the removal of introns from their pre–messenger RNAs (pre-
mRNAs), a process catalyzed by the spliceosome. In higher eukaryotes a large family of auxiliary factors known as SR
proteins can improve the splicing efficiency of transcripts containing suboptimal splice sites by interacting with distinct
sequences present in those pre-mRNAs. The yeast Saccharomyces cerevisiae lacks functional equivalents of most of
these factors; thus, it has been unclear whether the spliceosome could effectively distinguish among transcripts. To
address this question, we have used a microarray-based approach to examine the effects of mutations in 18 highly
conserved core components of the spliceosomal machinery. The kinetic profiles reveal clear differences in the splicing
defects of particular pre-mRNA substrates. Most notably, the behaviors of ribosomal protein gene transcripts are
generally distinct from other intron-containing transcripts in response to several spliceosomal mutations. However,
dramatically different behaviors can be seen for some pairs of transcripts encoding ribosomal protein gene paralogs,
suggesting that the spliceosome can readily distinguish between otherwise highly similar pre-mRNAs. The ability of
the spliceosome to distinguish among its different substrates may therefore offer an important opportunity for yeast
to regulate gene expression in a transcript-dependent fashion. Given the high level of conservation of core
spliceosomal components across eukaryotes, we expect that these results will significantly impact our understanding
of how regulated splicing is controlled in higher eukaryotes as well.
Citation: Pleiss JA, Whitworth GB, Bergkessel M, Guthrie C (2007) Transcript-specificity in yeast pre-mRNA splicing revealed by mutations in core spliceosomal components.
PLoS Biol 5(4): e90. doi:10.1371/journal.pbio.0050090
Introduction
The coding regions of most eukaryotic genes are inter-
rupted by introns, which must be removed for proper gene
expression. The removal of introns requires single-nucleotide
precision in order to faithfully convert genomic information
into functional protein. The process of intron removal is
performed by the spliceosome, a large ribonucleoprotein that
catalyzes two sequential transesterification reactions [1,2].
The spliceosome itself is highly conserved across all eukar-
yotes, consisting of five small nuclear RNAs (snRNAs) and well
over 100 proteins [3,4]. A combination of genetic and
biochemical experiments have revealed conformational
rearrangements in both RNA and protein components that
are required for the spliceosome to accurately process pre–
messenger RNA (pre-mRNA) transcripts [5]. About 50 of
these proteins can be considered core components of the
spliceosome in that their activity is required for cell viability
in budding yeast, whereas the remainder of the factors can be
deleted with little or no effect on cell growth under standard
laboratory conditions.
To date, the vast majority of what is known about the
mechanism of pre-mRNA splicing has been deduced from
experiments using, at most, a handful of transcripts. Yet it
remains unknown how well these transcripts represent the
behavior of the entire complement of spliceosomal sub-
strates. In higher eukaryotes, where genes are often inter-
rupted by multiple introns, it is known that the spliceosome
can utilize specific sequences present in individual transcripts
to regulate both quantitative and qualitative aspects of gene
expression [6,7]. Two large groups of proteins, the SR and
hnRNP families, are known to modulate splicing activity,
allowing the spliceosome to generate multiple distinct
proteins from a single genomic locus, significantly increasing
proteomic diversity. In particular, the sequence-specific
RNA-binding members of the SR family improve the
processing efficiency of introns containing suboptimal signals
at their 59 or 39 splice sites. Binding of the SR proteins to
enhancer sequences, which may be located in exons or
introns, facilitates recruitment of the core machinery to the
suboptimal splice sites.
By comparison to higher eukaryotes, splicing in the yeast
Saccharomyces cerevisiae appears much simpler in a number of
ways. Whereas more than 95% of human genes are
interrupted by an intron [8], only about 250 yeast genes, or
less than 5% of all genes, contain an intron [9]. Moreover, the
vast majority of the intron-containing genes in yeast contain
only a single intron, differing significantly from humans,
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where the average gene is interrupted by eight introns [8]. As
seen in Figure 1A, yeast introns tend to conform to very
strong consensus sequences at the branch point and at both
the 59 and 39 splice sites. Perhaps accordingly, only three SR-
like proteins have been identified in yeast, none of which is
known to regulate splicing activity. On the other hand, while
relatively few yeast genes are interrupted by introns, those
that are tend to be highly expressed and tightly regulated
genes. It has been previously shown, for example, that intron-
containing genes account for nearly one-third of total
cellular transcription [10]. Notably, several functional cate-
gories are overrepresented among intron-containing genes.
The most dramatic of these corresponds to transcripts that
encode ribosomal protein genes (RPGs): 102 of the 139 RPGs
in yeast contain introns. Interestingly, all yeast introns tend
to be small relative to those found in humans; the largest
yeast intron contains only 1,002 nucleotides, whereas many
human introns stretch to well over 10,000 nucleotides.
Nevertheless, there is a bimodal distribution of intron lengths
that has a strong correlation with gene function; introns
found in genes encoding ribosomal proteins tend to be
longer, while those in nonribosomal proteins are generally
shorter (Figure 1B).
Given the relative simplicity and similarity of intron-
containing transcripts in yeast and the limited role of the SR
proteins, it has been a reasonable expectation that the yeast
spliceosome would have a restricted capacity to distinguish
among its different intron-containing substrates. In this case,
the behavior of a few individual transcripts could be
extrapolated to accurately describe the behavior of most
spliceosomal substrates. The advent of splicing-specific
microarrays, which facilitate a simultaneous examination of
all intron-containing transcripts [11], allows us to directly ask
whether the spliceosome interacts similarly with all pre-
mRNAs, or whether transcript-specific differences can be
identified. Here we have used this approach to examine the
splicing responses of all ;250 intron-containing transcripts
resulting from inactivation of 18 different core components
of the spliceosome and five factors involved in up- or
downstream steps in pre-mRNA processing. Far from being
homogeneous in their effects on the different intron-
containing transcripts, these mutants reveal a remarkable
ability of the core components to differentiate among
transcripts. Interestingly, most ribosomal proteins are
encoded at two distinct genomic loci in yeast. Whereas the
coding sequences are nearly identical at these two locations,
the sequences of the introns that interrupt them are generally
quite dissimilar. For some of these paralogs, dramatic
differences can be seen in response to the different
spliceosomal mutations. The capacity of the spliceosome to
differentiate among substrates suggests that splicing offers an
important opportunity to regulate gene expression in a
transcript-specific manner.
Results
Monitoring Genome-Wide Changes in Splicing
To examine genome-wide changes in splicing in yeast, we
have designed microarrays similar to those previously
described [11] that allow us to distinguish between the
spliced and unspliced isoforms of transcripts derived from
intron-containing genes. As seen in Figure 2A, three different
oligos are used to target each intron-containing gene (see also
Materials and Methods). One oligo targets a portion of the
last exon and is used to detect changes in total transcript level
(probe T). A second oligo targets a region of the intron,
allowing us to detect changes in pre-mRNA levels (probe P),
while the third oligo targets the junction of the two exons,
allowing for a determination of changes in levels of mature
mRNA (probe M).
Because there are multiple, independent probes describing
the behavior of each intron-containing gene, analysis of a
splicing-specific microarray is inherently more complicated
than that of a standard expression array. In order to assess
the splicing behavior of any given transcript it is important to
simultaneously examine the changes in signal on all three
feature types. In analyzing data from splicing-specific micro-
arrays, others have generated splicing indices for each gene
by compressing the data derived from the different feature
types. For example, splicing changes can be represented as a
precursor/mature (PM) index by dividing the ratio of the
movement of the pre-mRNA feature by the ratio of the
mature mRNA feature [11,12]. Although this manipulation
simplifies the data, allowing them to be more easily examined
in the context of traditional microarray analyses, for reasons
described below we find that a more detailed understanding
of individual transcript behavior is achieved by considering
the independent movement of all three feature types
simultaneously.
Figures 2B and 2C show an example of such an analysis
derived from a comparison of RNA from a wild-type strain
and a strain harboring the temperature-sensitive prp2-1
mutation after both were shifted to the nonpermissive
temperature of 37 8C. The spliceosomal Prp2 protein is a
member of the DEAD/H box family of RNA-dependent
ATPases and plays an essential role in catalyzing an as yet
unidentified structural rearrangement required for activa-
tion of the spliceosome prior to the first chemical step [13].
As such, the primary result of a defect in Prp2 activity is
expected to be a broad decrease in pre-mRNA splicing. The
splicing profile resulting from this experiment, where each
horizontal line describes the behavior of a single gene, is
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Author Summary
The spliceosome is a large RNA-protein machine responsible for
removing the noncoding (intron) sequences that interrupt eukary-
otic genes. Nearly everything known about the behavior of this
machine has been based on the analysis of only a handful of genes,
despite the fact that individual introns vary greatly in both size and
sequence. Here we have utilized a microarray-based platform that
allows us to simultaneously examine the behavior of all intron-
containing genes in the budding yeast S. cerevisiae. By systematically
examining the effects of individual mutants in the spliceosome on
the splicing of all substrates, we have uncovered a surprisingly
complex relationship between the spliceosome and its full comple-
ment of substrates. Contrary to the idea that the spliceosome
engages in ‘‘generic’’ interactions with all intron-containing
substrates in the cell, our results show that the identity of the
transcript can differentially affect splicing efficiency when the
machine is subtly perturbed. We propose that the wild-type
spliceosome can also distinguish among its many substrates as
external conditions warrant to function as a specific regulator of
gene expression.
displayed for both a single timepoint (Figure 2B) and across
the time course of inactivation (Figure 2C). A simple
prediction for the behavior of a given transcript in an
experiment where the activity of a core spliceosomal
component is impaired is that the precursor species would
accumulate with a concomitant loss of the mature species.
Indeed, for many of the transcripts, including those shown
with a red bar in Figure 2C, this is precisely the pattern that is
observed: precursor species are seen to accumulate to nearly
ten times the normal level, and up to 90% of the mature
mRNA is lost. For most of these genes, the behavior of the
total mRNA probe closely follows that of the mature species,
suggesting that the majority of the transcripts for these genes
are present in their spliced forms. However, different profiles
are apparent for many other genes. For example, many show
robust accumulation of precursor species with very little
decrease in mature mRNA, including those shown with a
green bar in Figure 2C.
The different behaviors displayed by these two groups of
transcripts presumably reveal important differences in the
complex interplay of cellular machineries that define the
steady-state levels of both the precursor and mature forms of
each of these transcripts. For example, the rate of precursor
accumulation observed for a given transcript depends upon,
among other things, the transcription rate of that gene, the
degradation rate of the transcript, the rate at which the
transcript is normally spliced, and the extent to which its
splicing is inhibited. Likewise, the decrease in mature mRNA
is a function of both the extent of splicing inhibition and the
decay rate of the mature form of that transcript. For those
genes marked by the red bar in Figure 2C, the dramatic
decrease in levels of mature mRNA may be explained by
either a strong block to the production of mature species, a
rapid rate of decay of the mature species, or some
combination of both. By comparison, a less complete block
to splicing or a slower rate of mRNA decay may explain the
failure to detect significant decreases in mRNA for those
genes marked with the green bar. Importantly, the process of
creating splicing indices to describe the behavior of these
transcripts in many cases eliminates the ability to differ-
entiate between these scenarios. For example, genes which
show both a modest increase in precursor levels and a modest
decrease in mature mRNA levels generate nearly identical PM
index values as do genes that show a strong precursor
accumulation but little decrease in mature levels.
By simultaneously examining each of the feature types as
described above, the global splicing profile resulting from the
prp2-1 mutation shows that precursors rapidly accumulate for
about 80% of the intron-containing genes. While the detailed
behaviors of the different transcripts are varied, this result
appears to satisfy the simple prediction that defects in this
factor would result in defective splicing of all actively
transcribed genes. At least two different scenarios may
explain the failure to detect precursor accumulation for the
remaining 20% of the transcripts. It is almost certainly true
that some of the intron-containing genes are transcription-
ally quiescent during logarithmic growth conditions. Natu-
rally, no precursor accumulation would be expected for such
genes. Alternatively, these transcripts may be insensitive to
the particular defect introduced by the prp2-1 mutation.
Transcript Specificity of Spliceosomal Mutations
In order to further distinguish between transcript behav-
iors, we examined the RNA from strains containing muta-
tions in two additional core spliceosomal components: PRP5
and PRP8. Like PRP2, PRP5 encodes an essential member of
the DEAD/H box family of RNA-dependent ATPases. By
comparison with Prp2, the activity of Prp5 is required to
promote a molecular rearrangement earlier in the splicing
pathway, catalyzing the stable addition of the U2 small
nuclear ribonucleoprotein to the branch point sequence [14].
As with mutations in Prp2, loss-of-function mutations in Prp5
result in a block to splicing prior to completion of the first
chemical step. Notably, Prp5 and Prp2 are only transiently
associated with the spliceosome, whereas Prp8 is a stable
component of the U5 small nuclear ribonucleoprotein and is
thought to form the physical core of the spliceosome [15,16].
As with Prp5 and Prp2, most mutations in Prp8 block
spliceosomal activity prior to the first chemical step; however,
mutants have been isolated that can perform the first but not
the second transesterification reaction [17,18].
As seen in Figure 3A, strains containing the loss-of-
function mutations prp2-1, prp8-1, or prp5-1 all exhibit
conditional growth phenotypes, showing nearly wild-type
growth at 25 8C but an inability to support growth at 37 8C. A
comparison of growth at intermediate temperatures allows
these mutations to be ordered according to the strength of
the defect they impart: prp2-1 is the most severe defect as it is
unable to support growth above 25 8C; prp8-1 is slightly less
severe as it can support weak growth at 30 8C; and prp5-1 is
the weakest as it shows nearly wild-type growth even at 33 8C.
Figure 3B shows the time-resolved splicing profiles derived
from shifting each of these strains from 25 8C to 37 8C and
comparing them to a similarly treated wild-type strain.
Importantly, the ordering of the genes is consistent for all
three profiles, meaning that the behavior of a single intron-
containing gene can be seen by following a single horizontal
line across all three profiles.
As expected, inactivation of each of these factors results in
inhibition of splicing of a large number of intron-containing
Figure 1. Properties of Yeast Introns
(A) Consensus sequences found in yeast introns at 59 splice sites (59SS),
39 splice sites (39SS), and branch points (BP) [37].
(B) Distribution of yeast intron lengths shown for all introns (black),
introns only in ribosomal protein genes (green), or introns only in
nonribosomal protein genes (red).
doi:10.1371/journal.pbio.0050090.g001
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transcripts. Interestingly, while the overlapping set of tran-
scripts that are affected by inactivation of all three factors is
quite large, a closer examination suggested important differ-
ences in the particular transcripts whose splicing was affected
and prompted us to more carefully compare the profiles of
these mutants. Microarray experiments were performed that
directly compared the pairwise behaviors of these mutant
strains (Figure 3C), revealing three distinct classes of tran-
script behavior. The first class is composed of transcripts for
which splicing is equally affected by each of these mutations.
Approximately 100 transcripts behave in this fashion,
exemplified by those indicated with a red bar in Figure 3B
and 3C and highlighted in Figure 3E. For these transcripts,
the comparison of mutant versus wild-type behavior seen in
Figure 3B shows a strong splicing defect for all three
mutations. Further, the direct comparisons of the mutants
in Figure 3C show that each of the mutants causes a nearly
identical level of precursor accumulation and mature mRNA
reduction. Interestingly, found within this class is the tran-
script encoding Act1, which is widely used as a reporter for
both in vivo and in vitro splicing assays. Figure S2 shows the
results of quantitative RT-PCR experiments validating a
subset of these findings.
The second class is also composed of transcripts that
exhibit a canonical splicing defect in response to inactivation
of each of the single mutants, but for whom the magnitude of
the defect is different for each of the mutants. About 100
transcripts behave in this fashion, exemplified by those
indicated with a green bar in Figure 3B and 3C and
highlighted in Figure 3F. As with the first class, the experi-
ments shown in Figure 3B demonstrate that the splicing of
each of these transcripts is affected by each of the mutations;
however, the direct comparisons of the mutants in Figure 3C
show a larger precursor accumulation in the prp2-1 strain
than in either the prp8-1 or prp5-1 strains, and a larger
accumulation in the prp8-1 strain than in the prp5-1 strain.
Interestingly, the molecular splicing defects observed for this
class of transcripts correlate with the conditional growth
defects: the prp2-1 mutation produces the strongest pheno-
type, followed by the prp8-1 mutation, and finally the prp5-1
mutation. Notably, as indicated in Figure 3D, the vast
majority of the transcripts in this class encode RPGs, and
most RPGs belong to this class.
The final class is composed of a smaller number of
transcripts, those that exhibit splicing inhibition in response
to one or two of the mutant strains but not all three.
Examples of several transcripts belonging to this class are
shown in Figure 3G. Interestingly, the splicing of the Rps30a
transcript is dramatically affected by the prp2-1 mutation, but
shows little defect in response to either the prp8-1 or prp5-1
mutations. Conversely, the splicing of the Rpl19b transcript is
affected by both the prp8-1 and prp5-1 mutations, but is
largely unaffected by the prp2-1 mutation. Likewise, the Hnt1
transcript shows little defect in response to the prp8-1
mutation, while splicing of the Cox4 transcript is strongly
affected by the prp5-1 mutation but is only mildly affected in
the prp2-1 strain, the inverse of the ordering seen for the
second class of transcripts described above.
Given the predominance of RPG transcripts in the second
class of transcripts, we sought to identify properties of these
transcripts that might distinguish them from the others. As an
initial attempt to identify such differences, we asked whether
RPG transcripts showed a difference in splicing efficiency
relative to other transcripts under standard laboratory
growth conditions in wild-type cells. Quantitative RT-PCR
was performed using primers specific to both intron and
exon regions of 12 different intron-containing genes. Using
genomic DNA to generate standard curves, relative copy
numbers of both the precursor and total mRNA species were
then calculated and compared. As seen in Table 1, the RPG
transcripts tend to show exceptionally high levels of splicing
efficiency, particularly relative to non-RPG transcripts. The
relative copy numbers for the total mRNA features is in good
agreement with previously published mRNA abundance
values [19]. Interestingly, while the mature RPG transcripts
are quite abundant, there is in fact less detectable precursor
species for most RPGs than for non-RPGs. Nevertheless, as
seen in Figure S3, the ability to detect large increases in
precursor levels on our microarrays is independent of the
initial level of precursor mRNA.
The differences that we observed between mutations in
Figure 2. Monitoring Genome-Wide Changes in Pre-mRNA Splicing
(A) Oligos target either the pre-mRNA (P), the mature mRNA (M), or the
total level of mRNA (T) for each intron-containing gene.
(B) False color representation of the splicing response of 249 different
intron-containing transcripts at a single timepoint after inactivation of
Prp2 activity. Each horizontal line describes the behavior of a single
transcript.
(C) Time course from 0 to 30 min showing the kinetic response to
inactivation of Prp2. The gene order is identical to that shown in (B).
doi:10.1371/journal.pbio.0050090.g002
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different spliceosomal factors led us to ask whether distinct
mutations in a single factor might also cause such transcript-
specific responses. Shown in Figure 4A and 4B are the time-
resolved splicing profiles obtained from shifting strains
harboring either the prp8-1 mutation or the temperature-
sensitive prp8-101 mutation, respectively, to the nonpermis-
sive temperature and compared to similarly treated wild-type
strains. Strikingly, the splicing of most intron-containing
transcripts is almost completely unaffected by the prp8-101
mutation. Instead, this mutation appears to affect the splicing
of only a small number of transcripts. As it had previously
been shown that the prp8-101 mutation results in a defect in
catalyzing the second transesterification reaction [18], we
examined a defect in another factor necessary for the second
step, the helicase Prp16 [20]. Figure 4C shows the time-
resolved splicing profile derived from shifting a strain
harboring the cold-sensitive prp16-302 mutation to the
nonpermissive temperature of 16 8C. The broad splicing
defect seen for this mutant suggests that the differences
between the prp8-1 and prp8-101 splicing profiles are not
simply the result of comparing mutants defective for the first
or second chemical steps, but rather truly reflect allele-
specific differences in substrate specificity.
A Systematic Examination of Splicing Factors
The transcript-specific phenotypes that we observed with
this small subset of conditional mutants compelled us to
examine the effects of a much wider variety of spliceosomal
defects. To facilitate these experiments, a set of high-
throughput methods was developed that allowed us to
automate many of the steps in a microarray experiment
(see Materials and Methods). Using these methods, we
examined the effects of 18 different mutations in core
spliceosomal components and five additional mutations in
up- or downstream processes in mRNA processing. Figure S4
shows the different mutants that were examined using these
methods, the step in pre-mRNA processing at which they are
presumed to be defective, and their conditional growth
phenotype. Two different views of the data resulting from
these experiments are presented in Figure 5 and Figure S5.
By clustering the data across all of the experiments, Figure 5
tends to highlight those pre-mRNAs for which splicing is
negatively affected by most of the mutants. By comparison,
the clusters derived from each individual mutant shown in
Figure S5 allow a more detailed analysis of the behavior of the
pre-mRNAs in response to each individual mutation. As
expected, many of the spliceosomal mutations result in
splicing defects over a broad range of transcripts. Interest-
ingly, the splicing profile resulting from inactivation of the
brr5-1 mutant is quite similar to that seen for many other
canonical splicing mutants. While this mutant was originally
isolated as a splicing mutant [21], it has been subsequently
shown that Brr5 functions during 39 end processing and is the
yeast homolog of mammalian CPSF-73 [22,23]. By compar-
ison, the rna14-64 mutant, which is also defective in 39 end
formation [38], produces a noticeably different phenotype.
Importantly, a careful examination of the response of
individual transcripts to this panel of mutations makes clear
the fact that all transcripts are not equally affected by
mutations in core components. To exemplify this point,
Figure 6 shows the behavior of a select group of transcripts in
response to all of the mutations examined. For some
transcripts, such as the U3 small nucleolar RNA, splicing is
rapidly blocked by nearly all spliceosomal mutations, while
remaining largely unaffected by mutations in other mRNA
processing factors. Interestingly, while the prp19-1 mutation
does affect the splicing of many pre-mRNAs, it has little effect
on the splicing of this transcript. A comparison of the two U3
paralogs, SNR17A and SNR17B, whose mature products are
nearly identical but whose introns share little sequence
homology, also shows some differences in their responses to
some of the splicing mutants. For example, the U3a transcript
shows a stronger defect in response to the prp5-1 mutation
than the U3b transcript.
For some transcripts, the subset of mutations that affect
their splicing is much different. A dramatic example of this is
provided by the RPS30 paralogs. Whereas splicing of the
Rps30b transcript is affected by most of the splicing mutants
examined, the Rps30a transcript is not. The splicing of the
Rps30a transcript shows a strong defect in response to the
prp2-1 and prp16-302 mutations, a somewhat weaker response
to the prp28-1, brr2-1, brr1-1, and brr5-1 mutations, and very
Figure 3. Comparing the Cellular and Molecular Phenotypes of Three Different Spliceosomal Mutants
(A) Serial dilutions of a wild-type strain and strains containing the prp2-1, prp8-1, and prp5-1 mutations are grown at the temperatures indicated.
(B) Time-resolved splicing profiles for each of the three mutant strains compared to a wild-type strain.
(C) Time-resolved profiles resulting from microarrays directly comparing the indicated mutants. The order of genes is identical to that in (B).
(D) Transcripts that encode ribosomal protein genes are indicated with a red line. The order of genes is identical to that in (B) and (C).
(E) The identification and behavior of a subset of genes indicated with a green bar in (B) and (C). For these transcripts the comparison experiments
reveal a different level of precursor accumulation for each of the mutants.
(F) The identification and behavior of a subset of genes indicated with a red bar in (B) and (C). For these transcripts the comparison experiments show
an identical splicing defect for all three mutants.
(G) The identification and behaviors of a subset of genes whose splicing is affected by only one or two of the three mutants studied.
doi:10.1371/journal.pbio.0050090.g003
Table 1. Relative Copy Numbers of Total and Pre-mRNA
Determined by Quantitative RT-PCR
ORF Gene Intron Copies Exon Copies Efficiency M/P Ratio
YJL136c RPS21b 1 6 0.1 36,000 6 1,500 .99.9% 36,000
YBL027w RPL19b 4 6 1 110,000 6 2,900 .99.9% 28,000
YPR043w RPL43a 18 6 1.4 100,000 6 7,200 .99.9% 5,500
YBR191w RPL21a 3 6 1 15,000 6 900 .99.9% 5,000
YOR122c PFY1 13 6 2 36,000 6 3,100 .99.9% 2,800
YFL039c ACT1 37 6 8.8 17,000 6 1,700 99.8% 450
YKL081w TEF4 560 6 39 78,000 6 15,000 99.3% 140
YBR230c OM14 26 61.8 2,900 6 680 99.1% 110
YHR077c NMD2 65 6 5.5 3,000 6 510 97.8% 46
snR17a U3a 6,800 6 690 270,000 6 20,000 97.5% 40
YDL125c HNT1 710 6 120 5,300 6 710 86.6% 7.5
YHR041c SRB2 210 6 7.5 1,200 6 100 82.2% 5.6
doi:10.1371/journal.pbio.0050090.t001
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little defect in most of the other mutants. The RPL19 paralogs
also display divergent behaviors: whereas the Rpl19a tran-
script shows a similar defect in response to each of the
mutants, the Rpl19b transcript shows strong defects in
response to the prp8-1, prp5-1, and prp4-1 mutants, but less
severe defects in response to the other mutants. Differences
can also be seen between non-RPG transcripts by comparing
the behavior of the Act1 and Tef4 transcripts, for example.
Discussion
Here we describe the results of genome-wide experiments
designed to examine the in vivo responses of all intron-
containing transcripts in S. cerevisiae to mutations in core
spliceosomal factors. For largely technical reasons, most
experiments designed to study the efficiency of pre-mRNA
splicing to date have focused on a relatively small number of
transcripts, leaving open the question of how much variety
there is among different spliceosomal substrates. The experi-
ments presented here overcome this limitation by utilizing
splicing-specific microarrays that allow for the simultaneous
examination of all spliceosomal substrates. Splicing-specific
microarrays are particularly amenable to studies in budding
yeast, where there are a limited number of intron-containing
genes and there is very little alternative splicing. By using this
approach to examine the time-resolved effects of inactivating
23 different factors involved in pre-mRNA processing, the
work presented here reveals a complex relationship between
the activity of the core spliceosome and the full complement
of transcripts with which it must interact.
RPG Transcripts versus Non-RPG Transcripts
A large collection of data such as this offers a unique
opportunity to both compare and contrast the behaviors of
all 250 intron-containing transcripts according to their
individual responses to the different spliceosomal mutations.
From this perspective, the detailed comparison of mutations
in PRP2, PRP8, and PRP5 shown in Figure 3 provides
important information about the different spliceosomal
substrates, and suggests that all transcripts are not equally
affected by particular spliceosomal mutations. Each of these
three spliceosomal proteins plays an important role in
catalyzing events necessary for the first chemical step in
splicing. As such, mutations in these factors that reduce their
activity at this step can be expected to negatively affect the
splicing efficiency of all actively transcribed intron-contain-
ing genes. Indeed, while the majority of pre-mRNAs show
such a defect in response to the prp2-1, prp8-1, and prp5-1
mutations, the strengths of the splicing defects imparted by
these mutations are variable. Whereas the splicing of many
transcripts encoding factors other than ribosomal proteins is
equally inhibited by mutations in any of these three factors,
the strength of the defect observed in the splicing of most
ribosomal protein gene transcripts is dependent upon the
particular defect in the spliceosome. For these mutations, the
strength of the molecular splicing defect correlates with the
temperature sensitivity that the mutation imparts upon the
strain: prp2-1 causes the strongest defect and prp5-1 causes the
weakest. While the fraction of new transcript from any single
gene whose splicing is inhibited cannot be determined from
these experiments alone, these results nevertheless demon-
strate that a greater fraction of most RPG transcripts is
blocked by the prp2-1 mutation than by either the prp8-1 or
prp5-1 mutations. This difference is unlikely to simply reflect
differences in the severity or onset of the protein mutations
because nearly identical fractions of newly transcribed Act1,
for example, are blocked by all three of the spliceosomal
mutations. Rather, it suggests that the RPG-encoding tran-
scripts are fundamentally different from the other transcripts
in their susceptibility to these mutations.
We have not yet been able to identify any single feature of
intron-containing RPGs that explains this altered suscepti-
bility. While it is true that RPG introns tend to be longer than
non-RPG introns, and that RPGs tend to be among the more
highly transcribed genes in the genome, neither of these
features alone seems sufficient to explain the different
responses. The Act1 transcript, for example, is interrupted
by an intron that is similar in length (308 nucleotides) to an
average RPG intron (mean length of 402 nucleotides), and is
transcribed at a similar rate as many RPGs [24], yet its
behavior is distinct from that of most of the RPGs.
In an effort to identify properties that might differentiate
RPG transcripts from other intron-containing transcripts, we
used quantitative RT-PCR to determine the amount of
precursor and mature mRNA species present in wild-type
cells for a variety of different intron-containing genes. While
Figure 4. Two Different Alleles of Prp8 Produce Very Different Molecular
Phenotypes
Time-resolved splicing profiles derived from comparisons of prp8-1 (A),
prp8-101 (B), or prp16-302 (C), each compared to a wild-type strain. The
order of the genes is the same for all three profiles.
doi:10.1371/journal.pbio.0050090.g004
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Figure 5. A Global View of Defects in Pre-mRNA Splicing
Time-resolved splicing profiles derived from a panel of factors involved in pre-mRNA processing. The behavior of each individual transcript can be seen
by following a vertical line. The particular mutations examined are shown on the left. For each mutant, the order is indicated at the top right corner of
the figure.
doi:10.1371/journal.pbio.0050090.g005
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all 12 of the transcripts that we examined were efficiently
spliced (.80%), the RPG transcripts showed remarkably high
partitioning toward mature species. It is noteworthy that, in
spite of the high levels of total transcript present for most
RPGs, the amount of precursor species present is remarkably
low relative to the other intron-containing transcripts. For
example, while there is more than ten times as much total
Rps21b transcript in a cell as there is total Nmd2, 50 times
less Rps21b pre-mRNA can be detected as compared to Nmd2
pre-mRNA.
It is tempting to speculate that the different splicing
efficiencies and the different susceptibilities to spliceosomal
mutations displayed by the RPGs may be mechanistically
related. For example, while much recent progress has been
made in identifying protein components of the spliceosome
[4], it remains unknown whether the entire set of components
is required for splicing of all transcripts, or whether different
transcripts will utilize the activities of different subsets of
factors. Given that the promoter elements driving tran-
scription of RPGs are often different from non-RPGs, it is
easy to imagine that the complement of proteins present
during their splicing could also be different. The low levels of
precursor species detected under steady-state conditions for
the RPG transcripts suggest that the time between tran-
scription and splicing is shorter for these transcripts than for
non-RPG transcripts. In this light, it will be important to
determine whether unique spliceosomal complexes are
present during the splicing of RPG transcripts that allow
for enhanced catalytic rates of either the first or second
chemical steps of splicing. Alternatively, the rate of cotran-
scriptional loading of spliceosomal components onto RPG
transcripts could be enhanced. In this case, genome-wide
chromatin immunoprecipitation experiments might be ex-
pected to show higher levels of spliceosomal association with
the RPGs than the non-RPGs. In either case, the presence or
absence of unique, auxiliary spliceosomal components on the
RPG transcripts might also change the susceptibility of these
transcripts to defects in the core spliceosomal components.
All RPGs Are Not Equal
Importantly, not all RPG transcripts behave similarly in
these experiments. Whether considering the simple compar-
isons of the prp2-1, prp8-1, and prp5-1 mutations, or the entire
panel of factors as shown in Figures 5 and 6, several RPG
transcripts show significantly different behaviors from the
others. Compelling examples of these differences can be seen
among certain pairs of RPG paralogs. While many paralogs
display similar defects in response to the mutations, some
pairs show dramatically different responses to these mutants
(Figure 6). The RPS30 paralogs offer the most dramatic
example of these differences. Whereas splicing of the Rps30b
transcript is adversely affected by almost all of the spliceo-
somal mutations that we examined, splicing of the Rps30a
transcript is only affected by a small subset of these mutants.
The particular features unique to each of these transcripts
Figure 6. A Transcript-Specific View of Defects in Pre-mRNA Splicing
Time-resolved splicing profiles for individual transcripts derived from the same panel of factors shown in Figure 5.
doi:10.1371/journal.pbio.0050090.g006
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that underlie this differentiation remain unclear. Presumably
the ability of the Rps30a transcript, for example, to be
efficiently spliced in the prp8-1 mutant does not indicate that
Prp8 function is unnecessary for the splicing of this tran-
script. Rather, it suggests that the unique set of interactions
that this transcript forms with the spliceosome are less
sensitive to the defect imparted by this particular mutation in
Prp8. Importantly, because the Rps30a and Rps30b tran-
scripts behave so differently in response to so many
mutations, they should prove to be extremely useful as tools
for more traditional biochemical experiments designed to
understand the function of individual spliceosomal factors.
Deciphering Protein Function from Genome-Wide
Experiments
Most of the mutants that we have examined here were
isolated from conditional lethal screens. As such, this subset
of mutations may be biased towards those with strong growth
defects and hence broad transcript specificity. Perhaps
because of this, we have found it difficult to associate a
particular mechanistic role with any of these factors based
simply on the subset of pre-mRNAs whose splicing is affected
in these experiments. Rather, our findings seem to indicate
that the signature of introns that are affected by a particular
spliceosomal mutation is unique to that mutation. Never-
theless, it is tempting to imagine isolating other mutations in
these core components that affect the splicing of a smaller
subset of transcripts. Such mutations may be more difficult to
isolate, as they may be aphenotypic for growth under
standard laboratory conditions. Nevertheless, a genome-wide
splicing analysis of such a mutant may provide important
insights into the activity of the protein. Indeed, for the prp8-
101 mutation, which appears to represent such a mutant,
knowing the identity of transcripts that are either strongly
affected or unaffected provides important information for
designing more traditional biochemical experiments in the
future to examine the mechanism of its activity in the
spliceosome. Likewise, the genome-wide splicing profiles
derived from similar mutations in other factors might prove
more revealing about the mechanistic role of those factors.
Implications
Interestingly, the capacity of core spliceosomal compo-
nents to elicit transcript-specific changes in splicing activity
does not appear to be limited to yeast. Recent RNAi-
mediated depletion experiments targeting core spliceosomal
components in Drosophila melanogaster show differential effects
on splicing activity at alternative splice sites [25]. Given the
level of conservation of the core spliceosomal components
across eukaryotes, it seems highly likely that they could also
play important roles in augmenting the regulatory roles of
the SR and hnRNP families of proteins in higher eukaryotes.
The surprising finding that the macular degenerative disease
retinitis pigmentosa is associated with mutations in core
components of the spliceosome may in fact reflect such a role
[26–28]. As seen here for the prp8-101 mutation, the
mutations associated with retinitis pigmentosa may cause
defects in the splicing of a distinct group of transcripts,
presumably uniquely associated with retinal function.
We have recently shown that the yeast spliceosome can
rapidly and specifically alter the splicing efficiency of distinct
subsets of transcripts in response to at least two unrelated
environmental stresses (J.A.P., G.B.W., M.B. and C.G., unpub-
lished data). Notably, in response to amino acid starvation,
the splicing of virtually all RPG transcripts is specifically
downregulated. Given that S. cerevisiae lacks the large SR and
hnRNP protein families responsible for modulating tran-
script-specific splicing activity in higher eukaryotes, the
observations presented in the current work suggest that the
core spliceosomal components themselves could be targets of
environmental regulation. As seen with stable genetic
modifications here, post-translational modifications of these
components might similarly facilitate transcript-specific
regulation of pre-mRNA splicing. Such modifications would
allow the cell to both rapidly and specifically regulate the
production of translatable mRNA for particular transcripts
in a reversible manner. Whether or not the complex
relationships between transcripts and core spliceosomal
components revealed by these mutant studies represent
features of a system that has evolved to be the target of
biological regulation is a provocative question that remains
to be fully addressed.
The work presented here does however suggest that the
relationship between the spliceosome and the full comple-
ment of transcripts with which it must interact is much more
complex than previously believed. Important questions for
the future concern both the mechanism by which the
spliceosome distinguishes among these substrates and the
biological rationale for this specificity. The simple hypothesis
that all mutations in splicing factors that inhibit the growth
of a yeast cell would also inhibit the splicing of all (expressed)
intron-containing transcripts is inconsistent with our obser-
vations. The splicing efficiency of a given intron can not yet
be ascribed to obvious cis features of the intron, nor does the
biochemical activity presumed to be affected by a mutation
appear to dictate which introns will be affected. Instead, in
much the same way that transcription is now known to be
regulated by the combinatorial control of its holoenzyme, it
appears that the efficiency of pre-mRNA splicing may be
dependent upon the complexes present in the spliceosome as
well as the particular transcript upon which it assembles.
Materials and Methods
Sample collection and preparation. Unless otherwise indicated,
cultures were grown according to standard techniques in rich
medium supplemented with 2% glucose at 25 8C. Both mutant
strains and the corresponding wild-type strain were grown in parallel,
100 ml cultures until their optical densities were between A600 ¼ 0.5
and A600¼ 0.7. An initial 15 ml sample was collected at 25 8C prior to
initiation of the time course. Cells were collected by filtration using
Millipore HAWP0025 filters (http://www.millipore.com). The filters
were immediately frozen in N2(l). The culture flasks were then
transferred into water baths at either 16 8C or 37 8C, with additional
15 ml aliquots removed and collected at the appropriate times. Total
cellular RNA was isolated as previously described [29] with a few
exceptions. Tubes containing PhaseLock gel (Eppendorf, http://www.
eppendorf.com) were used during phase separation steps. Also, RNA
samples were precipitated using isopropanol.
For each microarray sample, cDNA was prepared from 25 lg of
total RNA in a 50 ll reaction mixture containing 50 mM TrisHCl (pH
8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 0.5 mM ATP, 0.5 mM
CTP, 0.5 mM GTP, 0.3 mM TTP, 0.2 mM aa-dUTP, 12.5 lg dN9
primer, and 5 ng murine Moloney leukemia virus (M-MLV) RT.
Primers were annealed to the RNA by heating to 65 8C for 5 min in
the presence of buffer and salt alone. Reactions were allowed to
incubate at 42 8C for at least 2 h. Remaining RNA was then
hydrolyzed by incubation for 15 min at 65 8C in the presence of 0.1 M
NaOH and 10 mM EDTA. This was neutralized with HCl, then
purified using a Zymo25 DNA purification column according to the
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manufacturer’s protocol (http://www.zymoresearch.com). Typical
yields ranged from 10 to 15 lg of cDNA from 25 lg of starting
material. The purified cDNA was then conjugated to the appropriate
fluorescent dye in a 10 ll reaction containing 50 mM sodium
bicarbonate (pH 9.0), 50% DMSO, and ;20 lg of NHS-derivatized
fluorophore. Reactions were incubated in the dark at 60 8C for 60
min, after which time the cDNA was repurified using a Zymo25 DNA
purification column.
High-throughput sample collection and preparation. Cultures were
grown in sets of four mutant strains along with their corresponding
wild-type strains in rich medium in flasks at 25 8C until their optical
densities were between A600 ¼ 0.5 and A600 ¼ 0.7. After the strains
were synchronized, the cultures were transferred into the wells of a
96-well growth plate at 25 8C. A reverse time course was then initiated
using a multichannel pipettor at the appropriate times to transfer the
cultures into a second 96-well plate submerged in a 37 8C water bath
(Figure S6). The entire time course was then collected by centrifu-
gation of the plate at 5,000g for 5 min. The cell pellets were then
frozen in N2(l). With the help of a Biomek FX liquid handling system
(Beckman Coulter, http://www.beckmancoulter.com), total cellular
RNA was then isolated using largely standard procedures. Typical
yields from a single 1.8 ml well ranged from 15 lg to 25 lg of total
RNA. For each well, cDNA synthesis was performed in a 50 ll reaction
as described above. After cDNA synthesis, the remaining RNA was
hydrolyzed by addition of 25 ll of 0.3 M NaOH/0.03 M EDTA and
heating to 60 8C for 15 min. This solution was neutralized by addition
of 25 lL of 0.3 M HCl. To purify the cDNA from this solution, 0.5 ml
of cDNA binding buffer (5 M GdnHCl, 30% isopropanol, 60 mM
potassium acetate, 90 mM acetic acid) was added to each well. This
material was passed over a 96-well glass-fiber filtration plate (Nalgene
Nunc, http://www.nalgenenunc.com). The filters were then washed
once with 0.5 ml of Wash I (10 mM TrisHCl [pH 8.0], 80% EtOH), and
once with 0.5 ml of Wash II (80% EtOH). Purified cDNA was then
eluted in two steps of 100 ll water. The appropriate dyes were then
coupled to the cDNA as described above. Fluorescently labeled cDNA
was then repurified using 96-well glass-fiber filtration plates as
described above.
Quantitative PCR. Total cellular RNA for quantitative RT-PCR
experiments was prepared as described above. Prior to conversion to
cDNA, the RNA was treated with DNase I (Fermentas, http://www.
fermentas.com) according to the manufacturer’s protocol. The cDNA
was then produced from 2 lg of total RNA in a 20 ll reaction mixture
containing 50 mM TrisHCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM
DTT, 0.5 mM each dNTP, 25 nM each gene-specific primer, 2.5 lg dN9
primer, and 5 ng M-MLV RT. Quantitative PCR was then performed
using an Opticon from MJ Research (http://www.mjresearch.com).
Primer sets used in this study are shown in Table S1. Relative copy
numbers shown in Table 1 are the result of triplicate measurements
from a single biological sample. Standard deviations were only
slightly higher when comparing biological replicates. A series of 10-
fold dilutions of genomic DNA covering a total range of 106
molecules was used to generate the standard curves. Genomic DNA
was purified using a ZR Fungal DNA kit (Zymo Research) according to
the manufacturer’s protocol. The copy numbers presented in the
Table have been normalized to the least abundant species detected in
these experiments, the precursor isoform of the RPS21b transcript.
Importantly, these copy numbers do not represent cellular copy
numbers.
Microarray design and construction. In an initial set of experi-
ments, we examined a variety of probe designs for their ability to
specifically and efficiently identify the mature mRNA species derived
from intron-containing genes. Whereas other splicing-specific micro-
arrays have utilized fixed-length probes that are geometrically
centered about the exon–exon junction, our best results were
obtained when the probe was thermodynamically balanced between
the two sides of the junction. Accordingly, oligonucleotides were
designed for every exon–exon junction such that the hybridization
energies were equivalent on either side of the junction (Figure S7).
Because of the different GC contents in the transcripts, the junction
oligos range in length from 28 nucleotides to 40 nucleotides.
Total mRNA feature probes (expression oligos) and premature
mRNA feature probes (intron oligos) 32 nucleotides in length were
designed using a previously described algorithm [30]. Intron and
junction oligos were designed to target 256 intron features in 246
different transcripts. Expression oligos were designed to target the
last exon of these 246 intron-containing transcripts, as well as 689
non–intron-containing transcripts and 99 noncoding RNAs (includ-
ing snRNAs and tRNAs).
Probes were printed on poly-lysine-coated glass slides using
standard techniques. Each probe was print on the array three times
by each of two different printing pins (for a total of six replicate
probe spots for each feature on each array; Figure S8). Prior to use,
arrays were preprocessed by 60 s of incubation at 25 8C in 33 SSC,
0.2% SDS. Arrays were then blocked using standard procedures.
Mutant and wild-type samples were then competitively hybridized
against one another using the Agilent Hybridization Buffer (Agilent,
http://www.agilent.com) at 60 8C for a period ranging from 12 to 16 h.
Image analysis, data preprocessing, and higher order analysis.
Microarray images were acquired using an Axon Instruments
GenePix 4000B scanner, reading at wavelengths of 635nm and
532nm (Axon Instruments, http://www.axon.com). Image analysis was
performed using Axon Instruments GenePix Pro version 4.0 (number
2500–137, Rev E, 2001). Ratio values derived from the median pixel
intensities for the 635 nm and 532 nm images of each spot were used
to represent probe behaviors in data preprocessing analysis. A
standardized qualitative assessment of array quality was performed
using the Bioconductor arrayQuality package (Paquet AC, Yang YH,
‘‘arrayQuality: Assessing array quality on spotted arrays,’’ version
1.4.0) [31,32]. Arrays were manually removed from further analysis if
they showed an above average spot intensity to ratio bias or a strong
spatial ratio bias (Figure S9). Spot ratio data were log2 transformed
and normalized within each array using global loess regression
implemented in the Bioconductor marray package [33]. All experi-
ments were performed as dye-flipped pairs using biological repli-
cates. Both within-array and between-array data replication were
analyzed for data quality (Figure S10) using the Bioconductor limma
package [34]. Linear analyses of the data were performed using
correlations of within-array and between-array spot replicates to
assess evidence for differential expression of each RNA species across
all of the experimental factors [35]. Results from these linear analyses
pertaining to conclusions highlighted in the text are shown in Tables
S2 and S3.
For downstream hierarchical clustering, feature ratio values were
calculated by averaging the median within-array spot replicate
measures between replicate arrays. Where appropriate, replicate
variation was used to weight feature measurements. Hierarchical
clustering was performed using the C Clustering Library version 1.32
[36]. Data were clustered using average linkage and Pearson
correlation as the distance measure.
All microarray data are available at the Gene Expression Omnibus
(GEO) repository at the National Center for Biotechnology Informa-
tion (http://www.ncbi.nlm.nih.gov/geo).
Supporting Information
Figure S1. Analysis of Splice Site Sequences and Transcript Behavior
in Comparisons between prp2-1, prp8-1, and prp5-1
Purple hashes denote the locations of introns with canonical and
noncanonical 59 and 39 splice sites and branch point sequences.
Found at doi:10.1371/journal.pbio.0050090.sg001 (5.0 MB EPS).
Figure S2. Validation of Microarrays Using Quantitative RT-PCR
(A) Quantitative RT-PCR (QPCR) experiments comparing wild-type
sampleswith prp2-1 (blue), prp8-1 (red), or prp5-1 (green) samples. Input
material was normalized using the average value obtained from probes
targeting both NRG1 and ECO1 transcripts. Values shown are derived
from triplicatemeasurements with error bars included.
(B) Comparison of QPCR and microarray values for genes shown in
(A).
Found at doi:10.1371/journal.pbio.0050090.sg002 (1.4 MB EPS).
Figure S3. The Extent of Precursor Accumulation Is Independent of
Initial Precursor Levels
Ratio values corresponding to the precursor species of the indicated
genes (top) derived from each of three mutant analyses are plotted
against initial precursor values as determined in Table 1.
Found at doi:10.1371/journal.pbio.0050090.sg003 (1.3 MB EPS).
Figure S4. Splicing Mutants Examined
Flow diagram of splicing and spliceosomal recycling pathways
showing putative stage of action of each interrogated allele. Alleles
in factors involved in 39 end processing and mRNA nuclear export
were also tested in this study.
Found at doi:10.1371/journal.pbio.0050090.sg004 (1.2 MB EPS).
Figure S5. Individual Splicing Profiles of Each Mutant Examined
Found at doi:10.1371/journal.pbio.0050090.sg005 (2.6 MB EPS).
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Figure S6. High-Throughput Sample Collection and Preparation
(A) Experimental time courses of temperature shifts were performed
in a 96-well format. Samples were from transferred from flasks at 25
8C to a 96-well plate shaking in a 37 8C bath in a reverse time course.
Matched wild-type and mutant samples were collected in the same 96-
well plate to ensure consistency in time points between hybridized
samples (right half and left half of the plate, respectively). Samples
were collected for two biological dye-flipped array replicates in each
96-well plate (top half and bottom half of the plate).
(B) Replicate samples of total RNA from wild-type cells grown to
optical densities between A600 ¼ 0.5 and A600 ¼ 0.7 at 30 8C purified
using either the standard or the high-throughput method (see
Materials and Methods) are shown here run on a 1% agarose gel
stained with ethidium bromide.
(C) RT efficiency of total RNA samples shown in (B).
Found at doi:10.1371/journal.pbio.0050090.sg006 (4.2 MB EPS).
Figure S7. Design Scheme for Mature mRNA Probes
To design mature mRNA probes (see Figure 2, probe M), a range of
possible target-binding energies between probe sequence and exon
sequence flanking exon–exon junctions were experimentally tested to
determine what binding energy would yield the highest signal to
noise. Sample probe sequences for three of the 12 tested targets are
shown here.
Found at doi:10.1371/journal.pbio.0050090.sg007 (1.2 MB PDF).
Figure S8. Microarray Design
Each biological sample is analyzed with three layers of data
replication. Each probe is printed on the arrays three times by each
of two different printing pins. Within a block (printed by a single
printing pin) the three spot replicates are printed in the same
column, separated vertically by eight rows. This vertical separation
allows for assessment of top-to-bottom spatial spot ratio and intensity
bias within each block. Block replicates (printed by two different
pins) are oriented on the array with 1808 rotational symmetry (for
example, block 5 and 12). Horizontal and vertical separation of blocks
allows for between-block assessment of both top-to-bottom and left-
to-right spatial spot ratio and intensity bias. Finally, each experiment
is assayed on two dye-flipped biological replicate arrays.
Found at doi:10.1371/journal.pbio.0050090.sg008 (7.0 MB PDF).
Figure S9. Global Quality Assessment for an Individual Microarray
An example of a standard qualitative assessment of array quality, with
array data from the prp8-1 versus wild-type 30-min 37 8C temperature
shift.
(A) Prenormalization spot log2 ratios (M-values) compared to total
spot intensities (A-values), with traces showing the average behavior
of each of the 16 blocks corresponding to individual printing pins.
(B) Spatial visualization of prenormalization M-value ranks across the
array.
(C) Hexagon binning plot showing distribution and density of global
Loess normalized M-values versus A-values.
(D) Spatial visualization of global Loess normalized M-values across
the array.
Found at doi:10.1371/journal.pbio.0050090.sg009 (2.3 MB EPS).
Figure S10. Quality Assessment of Within-Array and Between-Array
Replicate Agreement
(A) Dotplot of normalized, unfiltered, log2 ratios (M-values) for every
probe on the prp8-1 versus wild-type 30-min 37 8C temperature shift
array. Each set of six replicate probes is plotted on a single line
vertically. M-values for probes printed in the first set of printing
blocks (blocks 1–8) are plotted in blue, while M-values for probes
printed in the second set of printing blocks (blocks 9–16) are plotted
in orange. Spot replicate sets are arranged vertically based on the
median M-value of each set.
(B) Density trace (Gaussian smoothing) of standard deviations for
each replicate set on the array shown in (A). Three different density
traces are shown for the three different types of probe sets.
(C) Plot of normalized M-values on the prp8-1 versus wild-type 30-min
37 8C temperature shift array (Exp/Ref) and the matched dye-flipped
replicate array (Ref/Exp). Points corresponding to total mRNA
features, pre-mRNA features, and mature mRNA features are plotted
in blue, red, and green, respectively. Legend shows Pearson
correlations between the values for each of these types of features
in the two arrays.
Found at doi:10.1371/journal.pbio.0050090.sg010 (2.6 MB EPS).
Table S1. Oligonucleotide Sequences Used in QPCR Experiments
Found at doi:10.1371/journal.pbio.0050090.st001 (14 KB XLS).
Table S2. Evidence for Differential Expression in the prp2-1 Mutant
Evidence for differential expression of intron sequences after shifting
cells carrying the temperature sensitive prp2-1 mutation versus wild-
type cells to 37 8C for 30 min. The ‘‘ORF Name’’ column lists the
standard yeast ORF name associated with each intron. M values
represent averaged, log2-transformed ratios. The B-statistic repre-
sents the log posterior odds ratio.
Found at doi:10.1371/journal.pbio.0050090.st002 (46 KB XLS).
Table S3. Evidence for Differential Expression in the prp8-1 Mutant
Evidence for differential expression of intron sequences after shifting
cells carrying the temperature sensitive prp8-1 mutation versus wild-
type cells to 37 8C for 30 min. The ‘‘ORF Name’’ column lists the
standard yeast ORF name associated with each intron. M values
represent averaged, log2-transformed ratios. The B-statistic repre-
sents the log posterior odds ratio.
Found at doi:10.1371/journal.pbio.0050090.st003 (46 KB XLS).
Table S4. Evidence for Differential Expression in the prp5-1 Mutant
Evidence for differential expression of intron sequences after shifting
cells carrying the temperature sensitive prp5-1 mutation versus wild-
type cells to 37 8C for 30 minutes. The ‘‘ORF Name’’ column lists the
standard yeast ORF name associated with each intron. M values
represent averaged, log2-transformed ratios. The B-statistic repre-
sents the log posterior odds ratio.
Found at doi:10.1371/journal.pbio.0050090.st004 (46 KB XLS).
Table S5. Evidence for Differential Expression in the prp8-101Mutant
Evidence for differential expression of intron sequences after shifting
cells carrying the temperature sensitive prp8-101 mutation versus
wild-type cells to 378 C for 30 min. The ‘‘ORF Name’’ column lists the
standard yeast ORF name associated with each intron. M values
represent averaged, log2-transformed ratios. The B-statistic repre-
sents the log posterior odds ratio.
Found at doi:10.1371/journal.pbio.0050090.st005 (46 KB XLS).
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Note Added in Proof
Reference [38] is cited out of order because it was added while the article
was in proof.
PLoS Biology | www.plosbiology.org April 2007 | Volume 5 | Issue 4 | e900757
Transcript Specificity in Yeast Splicing
